Solifenacin (Bispec (5 mg)) is a urinary antispasmodic agent, prescribed for overactive bladder with or without incontinence.It works by blocking the action of certain chemicals in the body to help ...

Sept. 20, 2005 (Atlanta) — Results from the STAR trial, comparing two new-generation antimuscarinics solifenacin and tolterodine extended release (ER), suggest that solifenacin is superior in reducing ...

Studies comparing propiverine hydrochloride with newer antimuscarinic agents such as solifenacin succinate for the treatment of overactive bladder (OAB) in Japanese patients have not been performed.

Vesicare is the first overactive bladder treatment at an approved dose to show a statistically significant increase in warning time before urination Christchurch, New Zealand – December 1, 2006 – ...

Nov. 23, 2004 — The U.S. Food and Drug Administration (FDA) has approved solifenacin succinate for the treatment of overactive bladder, erlotinib as second-line therapy for locally advanced or ...

Patients with chronic overactive bladder (OAB) are usually treated long-term with antimuscarinic agents. However, adherence to treatment is poor—rates as low as 20% at 1 year have been reported in ...

PARIS—Patients with severely bothersome overactive bladder (OAB) symptoms who have failed treatment with tolterodine ER may benefit by switching to solifenacin, research suggests. At the Société ...

Do not use if you have ever had an allergic reaction to SOLIFENACIN VIATRIS or any of the ingredients listed at the end of the CMI. There are a number of circumstances in which a person should not use ...

Antimuscarinic bargains are the vesicare ditropan 15 mg treatment of side, but sexual events such as dry mouth may lead to vesicare ditropan 15 mg discontinuation. After a 2-week skateboarder, ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Solifenacin (Soliten (10 mg)) is a urinary ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The novel muscarinic M3 receptor antagonist DA8010 ...